A citation-based method for searching scientific literature

Nabil Amara, Jolyane Blouin-Bougie, Jalila Jbilou, Norrin Halilem, Jacques Simard, Réjean Landry. Fam Cancer 2016
Times Cited: 7







List of co-cited articles
21 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
502
42

Impact of a randomized controlled educational trial to improve physician practice behaviors around screening for inherited breast cancer.
Robert A Bell, Haley McDermott, Tonya L Fancher, Michael J Green, Frank C Day, Michael S Wilkes. J Gen Intern Med 2015
21
28

Delivery of genomic medicine for common chronic adult diseases: a systematic review.
Maren T Scheuner, Pauline Sieverding, Paul G Shekelle. JAMA 2008
214
28

Prompting Primary Care Providers about Increased Patient Risk As a Result of Family History: Does It Work?
Philip Zazove, Melissa A Plegue, Wendy R Uhlmann, Mack T Ruffin. J Am Board Fam Med 2015
14
28

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.
N Pashayan, S W Duffy, S Chowdhury, T Dent, H Burton, D E Neal, D F Easton, R Eeles, P Pharoah. Br J Cancer 2011
118
28

Incorporating genomics into breast and prostate cancer screening: assessing the implications.
Susmita Chowdhury, Tom Dent, Nora Pashayan, Alison Hall, Georgios Lyratzopoulos, Nina Hallowell, Per Hall, Paul Pharoah, Hilary Burton. Genet Med 2013
58
28


Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
309
28

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Heidi D Nelson, Miranda Pappas, Bernadette Zakher, Jennifer Priest Mitchell, Leila Okinaka-Hu, Rongwei Fu. Ann Intern Med 2014
157
28

Public health implications from COGS and potential for risk stratification and screening.
Hilary Burton, Susmita Chowdhury, Tom Dent, Alison Hall, Nora Pashayan, Paul Pharoah. Nat Genet 2013
86
28



Clinical decision support for genetically guided personalized medicine: a systematic review.
Brandon M Welch, Kensaku Kawamoto. J Am Med Inform Assoc 2013
66
28

Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.
Tracy Onega, Elisabeth F Beaber, Brian L Sprague, William E Barlow, Jennifer S Haas, Anna N A Tosteson, Mitchell D Schnall, Katrina Armstrong, Marilyn M Schapira, Berta Geller,[...]. Cancer 2014
88
28


Prevention of breast cancer in the context of a national breast screening programme.
A Howell, S Astley, J Warwick, P Stavrinos, S Sahin, S Ingham, H McBurney, B Eckersley, M Harvie, M Wilson,[...]. J Intern Med 2012
21
28

Population genetic testing for cancer susceptibility: founder mutations to genomes.
William D Foulkes, Bartha Maria Knoppers, Clare Turnbull. Nat Rev Clin Oncol 2016
63
28

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
28

Two decades after BRCA: setting paradigms in personalized cancer care and prevention.
Fergus J Couch, Katherine L Nathanson, Kenneth Offit. Science 2014
207
28

Refining Breast Cancer Risk Stratification: Additional Genes, Additional Information.
Allison W Kurian, Antonis C Antoniou, Susan M Domchek. Am Soc Clin Oncol Educ Book 2016
18
28


Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.
Phuong L Mai, Susan Thomas Vadaparampil, Nancy Breen, Timothy S McNeel, Louise Wideroff, Barry I Graubard. Am J Prev Med 2014
71
14


The role of genome sequencing in personalized breast cancer prevention.
Weiva Sieh, Joseph H Rothstein, Valerie McGuire, Alice S Whittemore. Cancer Epidemiol Biomarkers Prev 2014
9
14

Educational needs and preferred methods of learning among Florida practitioners who order genetic testing for hereditary breast and ovarian cancer.
Deborah Cragun, Andrea Doty Besharat, Courtney Lewis, Susan T Vadaparampil, Tuya Pal. J Cancer Educ 2013
12
14


Hereditary cancer predisposition syndromes.
Judy E Garber, Kenneth Offit. J Clin Oncol 2005
325
14

Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.
Evelyn P Whitlock, Jennifer S Lin, Elizabeth Liles, Tracy L Beil, Rongwei Fu. Ann Intern Med 2008
556
14

Direct-to-consumer personalized genomic testing.
Cinnamon S Bloss, Burcu F Darst, Eric J Topol, Nicholas J Schork. Hum Mol Genet 2011
60
14


Obstetrics/gynecology residents' knowledge of hereditary breast and ovarian cancer and Lynch syndrome.
Kaylene J Ready, Molly S Daniels, Charlotte C Sun, Susan K Peterson, Hope Northrup, Karen H Lu. J Cancer Educ 2010
16
14

Genetic assessment of breast cancer risk in primary care practice.
Wylie Burke, Julie Culver, Linda Pinsky, Sarah Hall, Susan E Reynolds, Yutaka Yasui, Nancy Press. Am J Med Genet A 2009
53
14

Knowledge of Lynch syndrome among obstetrician/gynecologists and general surgeons.
Melissa K Frey, Jolyn S Taylor, Sara J Pauk, Duncan Hughes, Harma K Turbendian, Katherine J Sapra, Kevin Holcomb. Int J Gynaecol Obstet 2014
11
14

Academic family physicians' perception of genetic testing and integration into practice: a CERA study.
Arch G Mainous, Sharleen P Johnson, Svetlana Chirina, Richard Baker. Fam Med 2013
33
14

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis.
Nora Pashayan, Stephen W Duffy, David E Neal, Freddie C Hamdy, Jenny L Donovan, Richard M Martin, Patricia Harrington, Sara Benlloch, Ali Amin Al Olama, Mitul Shah,[...]. Genet Med 2015
61
14


Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
146
14

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.
Roger Chou, Jennifer M Croswell, Tracy Dana, Christina Bougatsos, Ian Blazina, Rongwei Fu, Ken Gleitsmann, Helen C Koenig, Clarence Lam, Ashley Maltz,[...]. Ann Intern Med 2011
404
14

A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.
Tuya Pal, Deborah Cragun, Courtney Lewis, Andrea Doty, Maria Rodriguez, Cristi Radford, Zachary Thompson, Jongphil Kim, Susan T Vadaparampil. Genet Test Mol Biomarkers 2013
41
14

Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians.
Della Brown White, Vence L Bonham, Jean Jenkins, Nancy Stevens, Colleen M McBride. Cancer Epidemiol Biomarkers Prev 2008
36
14


A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians.
Maren T Scheuner, Alison B Hamilton, Jane Peredo, Taylor J Sale, Colletta Austin, Stuart C Gilman, M Scott Bowen, Caroline Lubick Goldzweig, Martin Lee, Brian S Mittman,[...]. Genet Med 2014
32
14

Patterns of cancer genetic testing: a randomized survey of Oregon clinicians.
Summer L Cox, Amy I Zlot, Kerry Silvey, Debi Elliott, Tara Horn, Amber Johnson, Richard F Leman. J Cancer Epidemiol 2012
23
14

Public Awareness of Direct-to-Consumer Genetic Tests: Findings from the 2013 U.S. Health Information National Trends Survey.
Tanya Agurs-Collins, Rebecca Ferrer, Allison Ottenbacher, Erika A Waters, Mary E O'Connell, Jada G Hamilton. J Cancer Educ 2015
32
14

Increasing Public Awareness of Direct-to-Consumer Genetic Tests: Health Care Access, Internet Use, and Population Density Correlates.
Lila J Finney Rutten, Sarah E Gollust, Sana Naveed, Richard P Moser. J Cancer Epidemiol 2012
30
14

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome.
Glenn E Palomaki, Monica R McClain, Stephanie Melillo, Heather L Hampel, Stephen N Thibodeau. Genet Med 2009
327
14


Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.
Sharon E Plon, H Paul Cooper, Bethany Parks, Shweta U Dhar, P Adam Kelly, Armin D Weinberg, Stephanie Staggs, Tao Wang, Susan Hilsenbeck. Genet Med 2011
77
14

Telegenetics: a systematic review of telemedicine in genetics services.
Jennifer S Hilgart, Julie A Hayward, Bernadette Coles, Rachel Iredale. Genet Med 2012
89
14

Prevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: findings from the Health Information National Trends Survey.
Jennifer M Taber, Christine Q Chang, Tram K Lam, Elizabeth M Gillanders, Jada G Hamilton, Sheri D Schully. Public Health Genomics 2015
16
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.